Insmed (INSM) Net Cash Flow (2010 - 2026)

Insmed's Net Cash Flow history runs 17 years deep, the most recent figure standing at $72.3 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 147.35% year-over-year to $72.3 million; the TTM figure through Mar 2026 stood at $179.5 million (up 192.97% YoY), while the FY2025 annual figure was -$45.5 million, down 161.54% from the prior year.
• Net Cash Flow was $72.3 million for Q1 2026 at Insmed, down from $175.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $880.1 million in Q2 2025 to a low of -$948.6 million in Q3 2025.
• Historically, Net Cash Flow has averaged -$7.8 million across 5 years, with a median of -$5.8 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow tumbled 3783.94% in 2023, then jumped 1752.77% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $660.5 million in 2022, then slumped by 100.87% to -$5.8 million in 2023, then surged by 1752.77% to $95.1 million in 2024, then soared by 84.76% to $175.7 million in 2025, then slumped by 58.85% to $72.3 million in 2026.
• The last three Net Cash Flow figures came in at $72.3 million (Q1 2026), $175.7 million (Q4 2025), and -$948.6 million (Q3 2025), per Business Quant data.